Carregant...

Structural and enzymatic analyses reveal the binding mode of a novel series of Francisella tularensis enoyl reductase (FabI) inhibitors

Due to structural and mechanistic differences between eukaryotic and prokaryotic fatty acid synthesis enzymes, the bacterial pathway, FAS-II, is an attractive target for the design of antimicrobial agents. We have previously reported the identification of a novel series of benzimidazole compounds wi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Mehboob, Shahila, Hevener, Kirk E, Truong, Kent, Boci, Teuta, Santarsiero, Bernard D, Johnson, Michael E
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3386789/
https://ncbi.nlm.nih.gov/pubmed/22642319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm300489v
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!